Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Masters

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 3, 2011
A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531Gregory A Masters, Xiaofei Wang, Lydia Hodgson, et al.
Clinical Lung Cancer|January 7, 2004
The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature reviewMehul K Soni, David Cella, Gregory A Masters, et al.
Journal of Thoracic Disease|December 2, 2015
Epithelioid inflammatory myofibroblastic sarcoma: a case reportDaniel E Sarmiento, Jessica A Clevenger, Gregory A Masters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Clinical Lung Cancer|December 5, 2003
Real-time clinical application of quality-of-life assessment in advanced lung cancerChih-Hung Chang, David Cella, Gregory A Masters, et al.
Hematology/Oncology Clinics of North America|April 19, 2005
Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment Of Cancer Therapy-Lung scaleZeeshan Butt, Kimberly Webster, Amy R Eisenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103Charles M Rudin, Ravi Salgia, Xiaofei Wang, et al.
Cancer|September 2, 2016
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113Rachel E Sanborn, Jyoti D Patel, Gregory A Masters, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trialsJohnny Kao, Suzanne D Conzen, Nora T Jaskowiak, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|May 3, 2011
A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531Gregory A Masters, Xiaofei Wang, Lydia Hodgson, et al.
Clinical Lung Cancer|January 7, 2004
The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature reviewMehul K Soni, David Cella, Gregory A Masters, et al.
Journal of Thoracic Disease|December 2, 2015
Epithelioid inflammatory myofibroblastic sarcoma: a case reportDaniel E Sarmiento, Jessica A Clevenger, Gregory A Masters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Clinical Lung Cancer|December 5, 2003
Real-time clinical application of quality-of-life assessment in advanced lung cancerChih-Hung Chang, David Cella, Gregory A Masters, et al.
Hematology/Oncology Clinics of North America|April 19, 2005
Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment Of Cancer Therapy-Lung scaleZeeshan Butt, Kimberly Webster, Amy R Eisenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103Charles M Rudin, Ravi Salgia, Xiaofei Wang, et al.
Cancer|September 2, 2016
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113Rachel E Sanborn, Jyoti D Patel, Gregory A Masters, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trialsJohnny Kao, Suzanne D Conzen, Nora T Jaskowiak, et al.
Pageof 5